D
Zai Lab Limited ZLAB
$20.51 -$0.10-0.49%
Recommendation
Sell
Prev Close
$20.51
Volume
576,474
Avg Vol (90D)
631,709
Market Cap
$2.01B
Dividend & Yield
--
52-Week Range
$13.48 - $31.22
P/E (TTM)
--
EPS (TTM)
-$30.69
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Zai Lab (ZLAB, $20.51) Aroon Indicator entered an Uptrend on September 13, 2024.
9/14/2024 - Tickeron - Stocks
Zai Lab (ZLAB, $20.61) Aroon Indicator entered an Uptrend on September 12, 2024.
9/13/2024 - Tickeron - Stocks
Zai Lab (ZLAB, $20.61) RSI Indicator left the overbought zone on September 12, 2024
9/13/2024 - Tickeron - Stocks
Buy Rating Affirmed for Zai Lab on Robust Drug Sales Growth and Strong Market Position
9/12/2024 - TipRanks Financial Blog
Zai Lab Limited (NASDAQ:ZLAB) Stock Position Raised by TD Asset Management Inc
9/12/2024 - Ticker Report
Zai Lab (ZLAB, $21.57) Aroon Indicator entered an Uptrend on September 11, 2024.
9/12/2024 - Tickeron - Stocks
Zai Lab (ZLAB, $21.57) RSI Indicator left the overbought zone on September 11, 2024
9/12/2024 - Tickeron - Stocks
Zai Lab (ZLAB, $19.35) RSI Indicator left the overbought zone on September 03, 2024
9/4/2024 - Tickeron - Stocks
Zai Lab Limited (ZLAB): Top ADR Stock According to Hedge Funds
8/29/2024 - Insider Monkey
Zai Lab (ZLAB, $18.76) RSI Indicator left the overbought zone on August 28, 2024
8/29/2024 - Tickeron - Technical Analysis
Analyzing Zai Lab (NASDAQ:ZLAB) and Karyopharm Therapeutics (NASDAQ:KPTI)
8/29/2024 - Ticker Report
Zai Lab (ZLAB, $19.33) RSI Indicator left the overbought zone on August 27, 2024
8/28/2024 - Tickeron - Technical Analysis
Zai Lab announced data from Phase 1 study of ZL-1218
8/27/2024 - The Fly
Zai Lab to Present Preliminary Data From Phase 1 Trial of ZL-1218, an Investigational Anti-CCR8 Antibody for the Treatment of Advanced Solid Tumors, at ESMO Congress 2024
8/27/2024 - Business Wire
Top 10 ADR Stocks To Buy According to Hedge Funds
8/26/2024 - Insider Monkey
Zai Lab's Revenue Soars, Losses Narrow in Interim Report
8/26/2024 - TipRanks Financial Blog
Zai Lab Announces Participation in September Investor Conferences
8/22/2024 - Business Wire
Zai Lab (ZLAB, $17.5) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 21, 2024
8/22/2024 - Tickeron - Stocks
Insider Selling: Zai Lab Limited (NASDAQ:ZLAB) Insider Sells 4,352 Shares of Stock
8/21/2024 - Ticker Report
Zai Lab Limited (NASDAQ:ZLAB) Short Interest Up 40.5% in July
8/14/2024 - Ticker Report
Zai Lab Rewards Employees with Equity Incentive
8/13/2024 - TipRanks Financial Blog
Q3 2024 EPS Estimates for Zai Lab Limited Decreased by Leerink Partnrs (NASDAQ:ZLAB)
8/13/2024 - Ticker Report
Q3 2024 EPS Estimates for Zai Lab Limited Decreased by Leerink Partnrs (NASDAQ:ZLAB)
8/13/2024 - Zolmax
Tidal Investments LLC Purchases Shares of 20,858 Zai Lab Limited (NASDAQ:ZLAB)
8/10/2024 - Zolmax
Tidal Investments LLC Purchases Shares of 20,858 Zai Lab Limited (NASDAQ:ZLAB)
8/10/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
$322.71M
EBITDA (TTM)
-$343.59M
EBIT (TTM)
-$353.92M
Net Income (TTM)
-$298.33M
Balance Sheet
Total Assets (Q)
$987.37M
Total Debt (Q)
$83.68M
Total Liabilities (Q)
$283.19M
Book Value Per Share (Q)
$71.75
Cash Flow
Cash from Operations (TTM)
-$202.47M
Cash from Investing (TTM)
$2.92M
Cash from Financing (TTM)
$68.82M
Net Change in Cash (TTM)
-$129.78M
Filings
Filing Date
Tuesday, August 6, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Week of Nov 4 and 8 (est)
Price History
Loading...
Beta
1.25
7-Day Total Return
4.43%
30-Day Total Return
12.63%
60-Day Total Return
13.94%
90-Day Total Return
22.96%
Year to Date Total Return
-21.30%
1-Year Total Return
-19.82%
2-Year Total Return
-58.29%
3-Year Total Return
-84.76%
5-Year Total Return
-40.12%
52-week Low
Apr 18, 2024 - $13.48
52-week High
Dec 19, 2023 - $31.22
Valuation
Market Cap
$2.01B - Mid Cap
Enterprise Value
$1.47B
Price/Sales (TTM)
0.62
Price/Book (Q)
0.29
Dividends and Shares
Shares Outstanding
9.76M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.zailaboratory.com
Phone Number
86 21 6163 2588
Address
Jinchuang Plaza
Building 1, Fourth Floor - 4560 Jinke Road
Pudong Shanghai, 201210
Country
China
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally... more
NASDAQ 09/13/2024 4:00PM Eastern Quotes delayed
Weiss Ratings